National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

buthionine sulfoximine
A synthetic amino acid. Buthionine sulfoximine irreversibly inhibits gamma-glutamylcysteine synthetase, thereby depleting cells of glutathione, a metabolite that plays a critical role in protecting cells against oxidative stress, and resulting in free radical-induced apoptosis. Elevated glutathione levels are associated with tumor cell resistance to alkylating agents and platinum compounds. By depleting cells of glutathione, this agent may enhance the in vitro and in vivo cytotoxicities of various chemotherapeutic agents in drug-resistant tumors. Buthionine sulfoximine may also exhibit antiangiogenesis activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:d,l-buthionine-s,r-sulfoximine
L-buthionine sulfoximine
Abbreviation:BSO
Chemical structure names:
  • 2-amino-4-(S-butylsulfonimidoyl) butanoic acid
  • butanoic acid, 2-amino-4-(S-butylsulfonimidoyl)-
  • S-(3-amino-3-carboxypropyl)-S-butylsulfoximine
  • S-(n-butyl)homocysteine sulfoximine



Previous:buserelin, Buspar, buspirone hydrochloride, busulfan, Busulfex
Next:c-Met inhibitor ARQ 197, c-myb antisense oligonucleotide G4460, caffeine, calcitriol, calcium carbonate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov